Solvias

Kaiseraugst, Switzerland Founded: 1999 • Age: 27 yrs Acquired By Water Street
Integrated RD services are provided for pharmaceuticals and allied sectors.
Annual revenue - Latest available
Total funding - 6 rounds
Employees - Tracked headcount
Investors 3 Known backers
Products 4 Services tracked
Competitors 10 Brand Intelligence

About Solvias

Solvias is a company based in Kaiseraugst (Switzerland) founded in 1999 was acquired by Water Street in June 2020. Solvias has completed 2 acquisitions, including Cergentis and Chemic Laboratories. Solvias offers products and services including Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing. Solvias operates in a competitive market with competitors including BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion, among others.

  • Headquarter Kaiseraugst, Switzerland
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Solvias Ag
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    $172.48 K (USD), Grant

    Jan 01, 2021

  • Investors
  • Employee Count
    Not available
  • Investments & Acquisitions
    Cergentis

    & 1 more

  • Acquired by
    Water Street

    (Jun 11, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Solvias

Solvias offers a comprehensive portfolio of products and services, including Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing.

Product name locked
Category locked
Primary

Develops and validates methods for pharmaceutical analysis and quality control

Product name locked
Category locked
Locked

Conducts testing and release for drug substances and products

Product name locked
Category locked
Locked

Evaluates product stability under various conditions

Product name locked
Category locked
Locked

Assesses impurities and contamination in materials

People of Solvias

Headcount 500-1000
Employee Profiles 110
Employee Profiles
People
Norberto Bonalumi
Head Of Business Development
People
Filippo Marangoni
Chemistry Scientist
People
Lilia Schneider
Senior Scientist Method Development New Services
People
Cliff Barrow
Leading Scientist Project Leader MS

Unlock access to complete

Funding Insights of Solvias

Investors in Solvias

Solvias has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union, Water Street and JLL Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Water Street is engaged in strategic investments in healthcare sectors.
Locked Locked Locked
JLL Partners is engaged in middle-market business transformation and investment.
Locked Locked Locked
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Locked Locked Locked
Premium access

Investor details for Solvias

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Solvias

Solvias has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cergentis and Chemic Laboratories.

Investments
Premium access

Investment portfolio details for Solvias

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Acquisitions
Company Name Description Domain Location Founded Year Amount
Kits and services for targeted gene sequencing are provided.
Locked Locked 2012 Locked
Contract chemistry organization offering cGMP analytical testing, small scale cGMP manufacturing and synthetic chemistry services
Locked Locked 1998 Locked
Premium access

Complete acquisition details for Solvias

Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.

  • Transaction dates
  • Acquired stakes
  • Disclosed values
  • Domains and locations

Verified entity values are shown only after access is granted.

Financial Statements - Solvias

Premium access

Detailed financials for Solvias

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Solvias Comparisons

Solvias Primary company
Description
Integrated R&D services are provided for pharmaceuticals and...
Location
Kaiseraugst, Switzerland
Founded Year
1999
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Solvias

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Solvias

Solvias operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Alderley Analytical, Tentamus, Nordic Bioscience and Advion, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Large-molecule bioanalysis is provided for biologics and biosimilars development.
Locked Locked Locked
Bioanalytical assays for drug development are developed and validated.
Locked Locked Locked
Analytical and quality assurance services are provided for diverse industries.
Locked Locked Locked
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
Locked Locked Locked
Microfluidics and mass spectrometry products are provided for clinical research.
Premium access

Detailed competitors of Solvias

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Solvias

Premium access

Complete news archive for Solvias

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Solvias

Solvias was founded in 1999 and raised its 1st funding round 16 years after it was founded.

Solvias is headquartered in Kaiseraugst, Switzerland. It is registered at Kaiseraugst, Aargau, Switzerland.

Solvias is offering integrated research and development services across the drug development services for the pharma and biotech and a range of other industries such as medical devices, cosmetics, agrochemicals, chemicals, and electronic materials. They have capabilities for offering analytical services, small molecule analysis, biopharmaceutical analysis, solid-state development, catalysis technology, custom synthesis manufacturing. Their service portfolio includes physicochemical characterization, comparability studies, methods development and validation, raw material testing, product release testing, stability storagetesting, cell-based bioassays, etc.

Solvias's top competitors include Alderley Analytical, BioAgilytix and Lightcast Discovery.

Solvias offers Analytical Method Development, cGMP Drug Testing, Stability Testing, and Extractables and Leachables Testing.

Solvias has made 2 acquisitions, including Cergentis, and Chemic Laboratories.

Solvias has 3 investors. Key investors include European Union, Water Street, and JLL Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available